Low false-negative rate of PCR analysis for detecting human papillomavirus-related cervical lesions

Journal of Clinical Microbiology

Volumn 36, Issue 9, 1998, Pages 2708-2713

  Zazove, Philip ^a,d   Reed, Barbara D ^a   Gregoire, Lucie ^b   Ferenczy, Alex ^c   Gorenflo, Daniel W ^a   Lancaster, Wayne D ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; COLPOSCOPY; CONDYLOMA; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVICITIS; UTERINE CERVIX CARCINOMA IN SITU; VAGINITIS; WART VIRUS;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0031872557     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.9.2708-2713.1998     Document Type: Article

References (47)

1. Amsel, R., P. A. Totten, C. A. Spiegel, K. C. Chen, D. Eschenbach, and K. K. Holmes. 1983. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am. J. Med. 74:14-22.
2. 1a. Azocar, J., S. M. Abad, H. Acosta, R. Hernandez, M. Gallegos, E. Pifano, R. Blanch, and A. Kramar. 1990. Prevalence of cervical dysplasia and HPV infection according to sexual behavior. Int. J. Cancer 45:622-625.
3. Bauer H. M., Y. Ting, C. E. Greer, J. C. Chambers, C. Tashiro, J. Chimera, A. Reingold, and M. M. Manos. 1991. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 265:472-477.
4. Bavin, P. J., J. A. Giles, A. Deery, J. Crow, P. D. Griffiths, V. C. Emery, and P. G. Walker. 1993. Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear report. Br. J. Cancer 67: 602-605.
5. Bosch, F. X., M. M. Manos, N. Munoz, M. Sherman, A. M. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, and K. V. Shah. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J. Natl. Cancer Inst. 87:796-802.
6. Burmer, G. C., J. D. Parker, J. Bates, K. East, and B. G. Kulander. 1990. Comparative analysis of human papillomavirus detection by polymerase chain reaction and Virapap/Viratype kits. Am. J. Clin. Pathol. 94:554-560.
7. Carmichael, J. A., J. F. Jeffrey, H. D. Steele, and I. D. Ohlke. 1984. The cytologic history of 245 patients developing invasive cervical carcinoma. Am. J. Obstet. Gynccol. 148:685-690.
8. Carmichael, J. A. 1991. The management of minor degrees of cervical dysplasia associated with the human papilloma virus. Yale J. Biol. Med. 64: 591-597.
9. Centers for Disease Control. 1989. Chronic disease reports: mortality trends - United States. 1979-1986. Morbid. Mortal. Weekly Rep. 38:189-193.
10. Centers for Disease Control. 1989. Cervical cancer control - Rhode Island. Morbid. Mortal. Weekly Rep. 38:659-662.
11. Cox, J. T., M. H. Schiffman, A. J. Winzelberg, and J. M. Patterson. 1992. An evaluation of human papillomavirus testing as part of referral to colposcopy clinics. Obstet. Gynecol. 80:389-395.
12. Cox, J. T., A. T. Lorincz. M. H. Schiffman, M. E. Sherman, A. Cullen, and R. J. Kurman. 1995. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am. J. Obstet. Gynecol. 172: 946-954.
13. Cuzick, J., G. Terry, L. Ho, T. Hollingworth, and M. Anderson. 1994. Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. Br. J. Cancer 69:167-171.
14. Cuzick, J., A. Szarewski, G. Terry, L. Ho, A. Hanby, P. Maddox, M. Anderson, G. Kocjan, S. T. Steele, and J. Guillebaud. 1995. Human papillomavirus testing in primary cervical screening. Lancet 345:1533-1536.
15. de Vet, H. C., P. G. Knipschild, H. J. Scheuten, J. Koudstaal, W. S. Kwee, D. Willebrand, F. Sturmans, and J. W. Arends. 1990. Interobserver variation in histopathological grading of cervical dysplasia. J. Clin. Epidemiol. 43:1395-1398.
16. Evander, M., K. Edlund, A. Gustavsson, M. Jonsson, R. Karlsson, E. Rylander, and G. Wadell. 1995. Human papillomavirus infection is transient in young women: a population-based cohort study. J. Infect. Dis. 171:1026-1030.
17. Feinstein, A. R. 1985. Clinical epidemiology: the architecture of clinical research, p. 182-186. W. B. Saunders Co., Philadelphia, Pa.
18. Gregoire, L. Unpublished data.
19. Gregoire, L., M. Arella, J. Campione-Piccardo, and W. D. Lancaster. 1989. Amplification of human papillomavirus DNA sequences by using conserved primers J. Clin. Microbiol. 27:2660-2665.
20. Gundersen, J. H., C. W. Schauberger, and N. R. Rowe. 1988. The Papanicolaou smear and the cervigram. A preliminary report. J. Reprod. Med. 33: 46-48.
21. Herrington, C. S., M. F. Evans, N. F. Hallam, F. M. Chamock, W. Gray, and J. D. McGee. 1995. Human papillomavirus status in the prediction of high-grade cervical intraepithelial neoplasia in patients with persistent low-grade cervical cytological abnormalities. Br. J. Cancer 71:206-209.
22. Ho, G. Y., R. D. Burk, S. Klein, A. S. Kadish, C. J. Chang, P. Palan, J. Basu, R. Tachezy, R. Lewis, and S. Romney. 1995. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J. Natl. Cancer Inst. 87:1365-1371.
23. Karlsson, R., M. Jonsson, K. Edlund, M. Evander, A. Gustavsson, E. Boden, E. Rylander, and G. Wadell. 1995. Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population-based study. Sex. Transm. Dis. 22:119-127.
24. Kataja, V., S. Syrjanen, R. Mantyjarvi, M. Yliskoski, S. Saarikoski, and K. Sydanen. 1992. Prognostic factors in cervical human papillomavirus infections. Sex. Transm. Dis. 19:154-160.
25. Koss, L. G. 1989. The Papanicolaou test for cervical cancer detection. A triumph and a tragedy. JAMA 261:737-743.
26. Kotloff, K. L., S. S. Wasserman, K. Russ, S. Shapiro, R. Daniel, W. Brown, A. Frost, S. O. Tabara, and K. Shah. 1998. Detection of genital human papillomavirus and associated cytological abnormalities among college women. Sex. Transm. Dis. 25:243-250.
27. Koutsky, L. A., K. K. Holmes, C. W. Critchlow, C. E. Stevens, J. Paavonen, A. M. Beckmann, T. A. DeRouen, D. A. Galloway, D. Vernon, and N. B. Kiviat. 1992. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N. Engl. J. Med. 327: 1272-1278.
28. Lorincz, A. T., M. H. Schiffman, W. J. Jaffurs, J. Marlow, A. P. Quinn, and G. F. Temple. 1990. Temporal associations of human papillomavirus infection with cervical cytologic abnormalities. Am. J. Obstet. Gynecol. 162:645-651.
29. Lorincz, A. T., R. Reid, A. B. Jenson, M. D. Greenberg, W. Lancaster, and R. J. Kurman. 1992. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet. Gynecol. 79:328-337.
30. Mann, W., N. Lonky, S. Massad, R. Scotti, J. Blanco, and S. Vasilev. 1993. Papanicolaou smear screening augmented by a magnified chemiluminescent exam. Int. J. Gynaecol. Obstet. 43:289-296.
31. Mobius, G. 1993. Cytological early detection of cervical carcinoma: possibilities and limitations. Analysis of failures. J. Cancer Res. Clin. Oncol. 119: 513-521. (Editorial.)
32. Moscicki, A. B., J. Palefsky, G. Smith, S. Siboshski, and G. Schoolnik. 1993. Variability of human papillomavirus DNA testing in a longitudinal cohort of young women. Obstet. Gynecol. 82:578-585.
33. Paterson, M. E., K. R. Peel, and C. A. Joslin. 1984. Cervical smear histories of 500 women with invasive cervical cancer in Yorkshire. Br. Med. J. Clin. Res. 289:896-898.
34. Reed, B. D., P. Zazove, L. Gregoire, D. W. Gorenflo, W. D. Lancaster, and M. T. Ruffin. 1993. Factors associated with human papillomavirus infection in women encountered in community-based offices. Arch. Fam. Med. 2: 1239-1248.
35. Rehder, K. E., and J. G. Blythe. 1988. Cytology and cervicography compared to cytology alone for human papillomavirus detection. Colposcopy Gynecol. Laser Surg. 4:1-7.
36. Remmink, A. J., J. M. Walboomers, T. J. Helmerhorst, F. J. Voorhorst, L. Rozendaal, E. K. Risse, C. J. Meijer, and P. Kenemans. 1995. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int. J. Cancer 61:306-311.
37. Ritter, D. B., A. S. Kadish, S. H. Verrnund, S. L. Romney, D. Villari, and R. D. Burk. 1988. Detection of human papillomavirus deoxyribonucleic acid in exfoliated cervicovaginal cells as a predictor of cervical neoplasia in a high-risk population. Am. J. Obstet. Gynecol. 159:1517-1525.
38. Schiffman, M. H., H. M. Bauer, R. N. Hoover, A. G. Glass, D. M. Cadell, B. B. Rush, D. R. Scott, M. E. Sherman, R. J. Kurman, S. Wacholder, et al. 1993. Epidemiologic evidence human papillomavirus infection causes most cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 85:958-964.
39. Schiffman, M. H. 1995. New epidemiology of human papillomavirus infection and cervical neoplasia. J. Natl. Cancer Inst. 87:1345-1347. (Editorial.)
40. Schneider, A., G. Meinhardt, E. M. De-Villiers, and L. Gissmann. 1987. Sensitivity of the cytologic diagnosis of cervical condyloma in comparison with HPV-DNA hybridization studies. Diagn. Cytopathol. 3:250-255.
41. Sherman, M. E., M. H. Schiffman, A. T. Lorincz, M. M. Manos, D. R. Scott, R. J. Kurrman, N. B. Kiviat, M. Stoler, A. G. Glass, and B. B. Rush. 1994. Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types. Am. J. Clin. Pathol. 102:182-187.
42. Shingleton, H. M., R. L. Patrick, W. W. Johnston, and R. A. Smith. 1995. The current status of the Papanicolaou smear. CA Cancer J. Clin. 45:305-320.
43. Slawson, D. C., J. H. Bennett, and J. M. Herman. 1993. Follow-up Papanicolaou smear for cervical atypia: are we missing significant disease? A HARNET Study. J. Fam. Pract. 36:289-293.
44. Yoshikawa, H., T. Kawana, K. Kitagawa, M. Mizuno, H. Yoshikura, and A. Iwamoto. 1991. Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Jpn. J. Cancer Res. 82:524-531.
45. Young, L. S., I. S. Bevan, M. A. Johnson, P. I. Blomfield, T. Bromidge, N. J. Maitland, and C. B. Woodman. 1989. The polymerase chain reaction: a new epidemiological tool for investigating cervical human papillomavirus infection. Br. Med. J. 298:14-28.
46. Young, N. A., S. Naryshkin, B. F. Atkinson, H. Ehya, P. K. Gupta, T. S. Kline, and R. D. Luff. 1994. Interobserver variability of cervical smears with squamous-cell abnormalities: a Philadelphia study. Diagn. Cytopathol. 11: 352-357.
47. Zazove, P., B. D. Reed, L. Gregoire, D. W. Gorenflo, W. D. Lancaster, M. T. Ruffin IV, and J. Hruszczyk. 1993. Presence of human papillomavirus infection of the uterine cervix as determined by different detection methods in a low-risk community-based population. Arch. Fam. Med. 2:1250-1258.